| 10025 | -1.051 | 7.572 | -7.089 | 9.882e-12 | 1.366e-10 | 15.8 | 10025 | MED16 | mediator complex subunit 16 | ENSG00000175221 | 604062 |
| 1022 | 1.106 | 8.614 | 10.53 | 3.02e-22 | 1.15e-20 | 39.68 | 1022 | CDK7 | cyclin-dependent kinase 7 | ENSG00000134058 | 601955 |
| 10499 | -1.637 | 8.615 | -14.41 | 4.588e-36 | 6.309e-34 | 71.22 | 10499 | NCOA2 | nuclear receptor coactivator 2 | ENSG00000140396 | 601993 |
| 10524 | -1.108 | 7.19 | -13.04 | 4.959e-31 | 4.169e-29 | 59.72 | 10524 | KAT5 | K(lysine) acetyltransferase 5 | ENSG00000172977 | 601409 |
| 10579 | -1.121 | 7.89 | -8.545 | 6.873e-16 | 1.45e-14 | 25.21 | 10579 | TACC2 | transforming, acidic coiled-coil containing protein 2 | ENSG00000138162 | 605302 |
| 1616 | -0.4032 | 7.026 | -5.178 | 4.153e-07 | 3.266e-06 | 5.427 | 1616 | DAXX | death-domain associated protein | ENSG00000231617, ENSG00000204209, ENSG00000227046, ENSG00000229396, ENSG00000206279, ENSG00000206206 | 603186 |
| 2033 | -0.7882 | 6.866 | -7.239 | 3.891e-12 | 5.622e-11 | 16.71 | 2033 | EP300 | E1A binding protein p300 | ENSG00000100393 | 114500, 180849, 602700, 613684 |
| 2274 | -0.4848 | 10.28 | -4.748 | 3.204e-06 | 2.2e-05 | 3.459 | 2274 | FHL2 | four and a half LIM domains 2 | ENSG00000115641 | 602633 |
| 23054 | -1.026 | 9.39 | -19.3 | 2.519e-54 | 1.439e-51 | 113 | 23054 | NCOA6 | nuclear receptor coactivator 6 | ENSG00000198646 | 605299 |
| 23636 | -1.298 | 10.38 | -15.65 | 1.099e-40 | 2.246e-38 | 81.78 | 23636 | NUP62 | nucleoporin 62kDa | ENSG00000213024 | 271930, 605815 |
| 29079 | -0.4557 | 8.341 | -4.066 | 6.126e-05 | 0.0003417 | 0.6421 | 29079 | MED4 | mediator complex subunit 4 | ENSG00000136146 | 605718 |
| 2959 | 1.361 | 9.922 | 13.9 | 3.523e-34 | 4.066e-32 | 66.91 | 2959 | GTF2B | general transcription factor IIB | ENSG00000137947 | 189963 |
| 5469 | -0.9546 | 8.827 | -8.706 | 2.229e-16 | 4.922e-15 | 26.32 | 5469 | MED1 | mediator complex subunit 1 | ENSG00000125686 | 604311 |
| 55062 | 0.8002 | 7.574 | 7.117 | 8.348e-12 | 1.162e-10 | 15.97 | 55062 | WIPI1 | WD repeat domain, phosphoinositide interacting 1 | ENSG00000070540 | 609224 |
| 55128 | -1.067 | 7.178 | -13.33 | 4.458e-32 | 4.053e-30 | 62.11 | 55128 | TRIM68 | tripartite motif containing 68 | ENSG00000167333 | 613184 |
| 5901 | -0.2564 | 13.01 | -5.549 | 6.372e-08 | 5.586e-07 | 7.241 | 5901 | RAN | RAN, member RAS oncogene family | ENSG00000132341 | 601179 |
| 6049 | -1.174 | 9.527 | -8.969 | 3.452e-17 | 8.242e-16 | 28.16 | 6049 | RNF6 | ring finger protein (C3H2C3 type) 6 | ENSG00000127870 | 133239, 604242 |
| 6256 | -0.5431 | 7.808 | -5.986 | 6.195e-09 | 6.236e-08 | 9.506 | 6256 | RXRA | retinoid X receptor, alpha | ENSG00000186350 | 180245 |
| 64324 | -0.9867 | 6.174 | -9.886 | 4.17e-20 | 1.276e-18 | 34.8 | 64324 | NSD1 | nuclear receptor binding SET domain protein 1 | ENSG00000165671 | 117550, 130650, 277590, 601626, 606681 |
| 672 | -0.4574 | 7.28 | -4.677 | 4.437e-06 | 2.984e-05 | 3.146 | 672 | BRCA1 | breast cancer 1, early onset | ENSG00000012048 | 113705, 114480, 604370, 614320 |
| 6879 | -0.3917 | 9.693 | -6.347 | 8.222e-10 | 9.204e-09 | 11.47 | 6879 | TAF7 | TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa | ENSG00000178913 | 600573 |
| 7041 | -1.739 | 8.342 | -14.68 | 4.778e-37 | 7.143e-35 | 73.46 | 7041 | TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | ENSG00000140682 | 602353 |
| 7205 | -1.17 | 7.294 | -7.738 | 1.597e-13 | 2.673e-12 | 19.85 | 7205 | TRIP6 | thyroid hormone receptor interactor 6 | ENSG00000087077 | 602933 |
| 7376 | -1.028 | 6.766 | -8.092 | 1.524e-14 | 2.806e-13 | 22.16 | 7376 | NR1H2 | nuclear receptor subfamily 1, group H, member 2 | ENSG00000131408 | 600380 |
| 7421 | 0.5266 | 6.656 | 4.007 | 7.795e-05 | 0.0004272 | 0.4139 | 7421 | VDR | vitamin D (1, 25- dihydroxyvitamin D3) receptor | ENSG00000111424 | 166710, 277440, 601769 |
| 7533 | -0.7826 | 8.591 | -6.455 | 4.406e-10 | 5.08e-09 | 12.08 | 7533 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | ENSG00000128245 | 113508 |
| 8202 | 1.138 | 7.438 | 10.39 | 9.093e-22 | 3.321e-20 | 38.59 | 8202 | NCOA3 | nuclear receptor coactivator 3 | ENSG00000124151 | 601937 |
| 8204 | -1.626 | 9.554 | -19.65 | 1.214e-55 | 7.309e-53 | 116 | 8204 | NRIP1 | nuclear receptor interacting protein 1 | ENSG00000180530 | 602490 |
| 8554 | 0.6261 | 7.26 | 4.636 | 5.338e-06 | 3.55e-05 | 2.969 | 8554 | PIAS1 | protein inhibitor of activated STAT, 1 | ENSG00000033800 | 603566 |
| 8638 | 1.43 | 5.462 | 10.97 | 1.017e-23 | 4.382e-22 | 43.03 | 8638 | OASL | 2'-5'-oligoadenylate synthetase-like | ENSG00000135114 | 603281 |
| 9031 | -0.3864 | 9.054 | -4.951 | 1.242e-06 | 9.046e-06 | 4.37 | 9031 | BAZ1B | bromodomain adjacent to zinc finger domain, 1B | ENSG00000009954 | 605681 |
| 9320 | -0.3749 | 10.39 | -4.302 | 2.304e-05 | 0.0001383 | 1.572 | 9320 | TRIP12 | thyroid hormone receptor interactor 12 | ENSG00000153827 | 604506 |
| 9604 | -1.032 | 8.153 | -9.839 | 5.936e-20 | 1.794e-18 | 34.45 | 9604 | RNF14 | ring finger protein 14 | ENSG00000013561 | 605675 |
| 9862 | -0.9939 | 7.315 | -7.777 | 1.232e-13 | 2.086e-12 | 20.11 | 9862 | MED24 | mediator complex subunit 24 | ENSG00000008838 | 607000 |
| 9968 | -0.5827 | 7.099 | -5.643 | 3.907e-08 | 3.532e-07 | 7.716 | 9968 | MED12 | mediator complex subunit 12 | ENSG00000184634 | 300188, 305450, 309520 |
| 9969 | -0.7909 | 10.35 | -8.507 | 8.954e-16 | 1.869e-14 | 24.95 | 9969 | MED13 | mediator complex subunit 13 | ENSG00000108510 | 603808 |